The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers

scientific article

The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1592/PHCO.27.10.1361
P698PubMed publication ID17896891

P2093author name stringWilliam P Forbes
Margaret Connolly
Helen S Pentikis
Carol B Trapnell
Doug K Bettenhausen
P2860cites workAntibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.Q34504027
Rifampin and rifabutin drug interactions: an updateQ34628553
Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotypingQ44259193
Rifaximin: a novel nonabsorbed rifamycin for gastrointestinal disordersQ44662618
Differentiation of intestinal and hepatic cytochrome P450 3A activity with use of midazolam as an in vivo probe: effect of ketoconazole.Q51431176
Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.Q55033133
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectpharmacokineticsQ323936
midazolamQ423071
P304page(s)1361-1369
P577publication date2007-10-01
P1433published inPharmacotherapyQ7180800
P1476titleThe effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers
P478volume27